Literature DB >> 3048352

Structure of the met protein and variation of met protein kinase activity among human tumour cell lines.

P R Tempest1, M R Stratton, C S Cooper.   

Abstract

An in vitro autophosphorylation assay has been used to demonstrate that there is considerable variation in met associated protein kinase among human tumour cell lines. Of particular note was the very high level of autophosphorylation of the 140 kD met protein (p140met) in experiments with A431 human cervical carcinoma cells. In contrast in experiments with Daoy human medulloblastoma cells we failed to detect phosphorylation of p140met; instead a high level of phosphorylation of a 132 kD protein was observed. To help understand the basis for the variation in kinase activity and to learn more about the structure of the mature met protein we have analysed p140met in SDS-polyacrylamide gels under non-reducing conditions. Under these conditions the met protein had an apparent molecular weight of 165,000 indicating that the mature met protein may exist as an alpha beta complex in which p140met (designated the beta subunit) is joined by disulphide bonds to a smaller, 25 kD, alpha-chain. We have identified a potential proteolytic cleavage site with the sequence Lys-Arg-Lys-Lys-Arg-Ser at amino acids 303-308 in the human met protein that may account for cleavage of the met protein into alpha and beta subunits.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048352      PMCID: PMC2246495          DOI: 10.1038/bjc.1988.150

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Mechanism of met oncogene activation.

Authors:  M Park; M Dean; C S Cooper; M Schmidt; S J O'Brien; D G Blair; G F Vande Woude
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

2.  The met oncogene: a new member of the tyrosine kinase family and a marker for cystic fibrosis.

Authors:  M Park; M Gonzatti-Haces; M Dean; D G Blair; J R Testa; D D Bennett; T Copeland; S Oroszlan; G Vande Woude
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

3.  Activation of the met oncogene in the human MNNG-HOS cell line involves a chromosomal rearrangement.

Authors:  P R Tempest; B R Reeves; N K Spurr; A J Rance; A M Chan; P Brookes
Journal:  Carcinogenesis       Date:  1986-12       Impact factor: 4.944

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Role of glycosylation in the processing of newly translated insulin proreceptor in 3T3-L1 adipocytes.

Authors:  G V Ronnett; V P Knutson; R A Kohanski; T L Simpson; M D Lane
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

6.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.

Authors:  A Ullrich; J R Bell; E Y Chen; R Herrera; L M Petruzzelli; T J Dull; A Gray; L Coussens; Y C Liao; M Tsubokawa
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

7.  The activated human met gene encodes a protein tyrosine kinase.

Authors:  P R Tempest; C S Cooper; G N Major
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

8.  Nerve growth factor receptors on human melanoma cells in culture.

Authors:  R N Fabricant; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

9.  Amplification and overexpression of the met gene in spontaneously transformed NIH3T3 mouse fibroblasts.

Authors:  C S Cooper; P R Tempest; M P Beckman; C H Heldin; P Brookes
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

10.  Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.

Authors:  A Ullrich; A Gray; A W Tam; T Yang-Feng; M Tsubokawa; C Collins; W Henzel; T Le Bon; S Kathuria; E Chen
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  17 in total

1.  The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation.

Authors:  L Naldini; E Vigna; R Ferracini; P Longati; L Gandino; M Prat; P M Comoglio
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).

Authors:  A Mondino; S Giordano; P M Comoglio
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

3.  C-terminal truncated forms of Met, the hepatocyte growth factor receptor.

Authors:  M Prat; T Crepaldi; L Gandino; S Giordano; P Longati; P Comoglio
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

Review 4.  MET receptor tyrosine kinase as an autism genetic risk factor.

Authors:  Yun Peng; Matthew Huentelman; Christopher Smith; Shenfeng Qiu
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

Review 5.  Control of cortical synapse development and plasticity by MET receptor tyrosine kinase, a genetic risk factor for autism.

Authors:  Xiaokuang Ma; Shenfeng Qiu
Journal:  J Neurosci Res       Date:  2019-11-19       Impact factor: 4.164

6.  Anti-c-Met antibodies recognising a temperature sensitive epitope, inhibit cell growth.

Authors:  Julin S Wong; Emma Warbrick; Borek Vojtesk; Jeffrey Hill; David P Lane
Journal:  Oncotarget       Date:  2013-07

Review 7.  The role of non-ras transforming genes in chemical carcinogenesis.

Authors:  C S Cooper
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

8.  Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.

Authors:  G J Dougherty; P M Landorp; D L Cooper; R K Humphries
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  Structural basis of the activation of c-MET receptor.

Authors:  Emiko Uchikawa; Zhiming Chen; Guan-Yu Xiao; Xuewu Zhang; Xiao-Chen Bai
Journal:  Nat Commun       Date:  2021-07-01       Impact factor: 14.919

10.  Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.

Authors:  K Rygaard; T Nakamura; M Spang-Thomsen
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.